openPR Logo
Press release

United States 7MM Digital Therapeutics for Diabetes Market: FDA Clearance & Clinical Validation Mandate By 2025-2033 | Major Companies - Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc.

11-20-2025 11:23 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

7MM Digital Therapeutics for Diabetes Market

7MM Digital Therapeutics for Diabetes Market

The 7MM Digital Therapeutics for Diabetes Market size reached US$ 961.09 million in 2024 and is expected to reach US$ 2,578.46 million by 2033, growing at a CAGR of 11.7% during the forecast period 2025-2033.

According to DataM Intelligence Comprehensive Report has released its latest report on the "7MM Digital Therapeutics for Diabetes Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/7mm-digital-therapeutics-for-diabetes-market?ca

Latest M & A:

The diabetes segment held a dominant market share in digital therapeutics, driven by the rising global prevalence of diabetes, with solutions like mobile apps, wearables, and real-time glucose monitoring improving disease management and patient adherence.​

Major companies actively developing and marketing digital therapeutics for diabetes include Welldoc, Omada Health, Livongo, and Dexcom, with a focus on integrated, AI-powered, and personalized care solutions.​

The Asian-Pacific region, particularly India and China, is witnessing rapid growth in digital health, with market sizes in India estimated at USD 219.41 million in 2025, expected to grow at a CAGR of 6.78%, driven by smartphone penetration and government initiatives.​

Increasing adoption of remote monitoring, telemedicine, and AI-based analytics for diabetes management are key factors propelling market growth.​

The primary drivers include rising diabetes prevalence, advancements in digital health technologies, and demand for cost-effective, scalable care models.​

Challenges include data privacy concerns, lack of reimbursement policies in certain regions, and digital literacy barriers among older populations.​

Regulatory approvals and clinical validation studies have further accelerated the uptake of digital therapeutics in diabetes management globally.​

Industry Developments:

USA:

Major innovations include AI-enabled apps integrating with continuous glucose monitors (CGMs) and smart insulin pens to provide real-time personalized treatment guidance, enhancing compliance and health outcomes.

Companies like Welldoc (BlueStar) and Omada Health are leading with platforms that offer integrated diabetes management solutions incorporating behavioral coaching and data analytics.

Market growth is supported by increased smartphone penetration, telehealth adoption, and strong investments in digital health technologies.

Data privacy and security concerns remain key challenges affecting adoption and regulatory compliance.

Japan:

Japan is witnessing steady adoption of digital therapeutics for diabetes, driven by government support for digital health and increasing smartphone use.

Innovations focus on integrating digital therapeutics with existing healthcare systems to support personalized diabetes management, leveraging real-time glucose monitoring and AI-driven coaching.

The market growth aligns with Japan's broader healthcare digitization initiatives and commitment to improving chronic disease outcomes.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/7mm-digital-therapeutics-for-diabetes-market?ca

Major Key Player:

7MM digital therapeutics for diabetes market include Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc., Abbott Laboratories, mySugr GmbH, Dexcom, Inc., Health2Sync, iHealth Labs Inc. and Medtronic plc

Key Segments:

➥ By Product Type: Software Solutions, Hardware Solutions

➥ By Application: Type-1 Diabetes, Type-2 Diabetes, Pre-Diabetes

➥ By End-User: Hospitals, Specialty Clinics, Homecare Settings, Others

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=7mm-digital-therapeutics-for-diabetes-market?ca

Product Launches

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/7mm-digital-therapeutics-for-diabetes-market?ca

Latest News

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?ca

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States 7MM Digital Therapeutics for Diabetes Market: FDA Clearance & Clinical Validation Mandate By 2025-2033 | Major Companies - Welldoc, Inc., Omada Health Inc., Glooko, Inc., Azumio Inc. here

News-ID: 4280092 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Critical Minerals Market to hit US$ 586.63 billion by 2032, North America led 41% of global market share | key Players:- Albemarle Corporation, Lynas Rare Earths, MP Materials.
Critical Minerals Market to hit US$ 586.63 billion by 2032, North America led 41 …
Critical Minerals Market Size reached US$ 328.19 billion in 2024 and is expected to reach US$ 586.63 billion by 2032, growing with a CAGR of 7.53% during the forecast period 2025-2032. The global critical minerals market is experiencing unprecedented growth, primarily driven by the accelerating transition to clean energy technologies. According to the International Energy Agency (IEA), the market size of key energy transition minerals doubled over the past five
Defense Electronics Market Set for Steady Growth to USD 254.51 Billion by 2032, Led by North America's 47% Global Market Share | DataM Intelligence
Defense Electronics Market Set for Steady Growth to USD 254.51 Billion by 2032, …
The Global Defense Electronics Market reached USD 173.98 billion in 2024 and is expected to reach USD 254.51 billion by 2032, growing at a steady CAGR of 4.87% during the forecast period 2025-2032. Market growth is driven by rising global defense modernization programs, increasing investments in advanced communication, surveillance, and electronic warfare systems, and the growing need for intelligence-driven military operations. Additionally, the integration of AI, unmanned systems, and cyber-secure electronics
Streaming Analytics Market to Reach US$ 89.4 Billion by 2031 | Strong 32% CAGR | North America Leads with 40% Share | Key Players: IBM, Oracle, Microsoft, SAP
Streaming Analytics Market to Reach US$ 89.4 Billion by 2031 | Strong 32% CAGR | …
The Global Streaming Analytics Market reached US$ 12.8 billion in 2023 and is expected to reach US$ 89.4 billion by 2031, growing at a CAGR of 32% during the forecast period 2024-2031. The market is expanding rapidly as enterprises across industries adopt real-time analytics to enhance decision-making, improve operational efficiency, detect anomalies, and respond instantly to dynamic business environments. The increasing use of IoT devices, growth in digital transactions, and
Cyber Physical Systems Market Set for Robust Growth to USD 405.91 Billion by 2032, Led by North America's 38% Global Market Share | DataM Intelligence
Cyber Physical Systems Market Set for Robust Growth to USD 405.91 Billion by 203 …
The Global Cyber-Physical Systems Market reached USD 137.40 billion in 2024 and is expected to reach USD 405.91 billion by 2032, growing at a robust CAGR of 14.50% during the forecast period 2025-2032. Market growth is driven by the rapid adoption of Industry 4.0 technologies, expanding integration of IoT and automation across manufacturing, and rising demand for real-time monitoring and predictive maintenance. Increasing deployment of smart infrastructure, advancements in robotics and

All 5 Releases


More Releases for Diabetes

Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size? The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools. The diabetes pen market is projected to grow strongly, reaching $40.17 billion
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28). According to Type-2 Diabetes Market
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end
Self-Monitoring Blood Glucose Devices Market Study by Advance Application [Type …
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Monitoring of blood glucose is an essential step in diabetes management. Blood glucose monitoring devices are predominantly used to monitor a patient’s blood glucose level. Self-monitoring blood glucose (SMBG) devices are easy-to-use and enable people to monitor their